CALDOPA

This brand name is authorized in Nigeria.

Active ingredients

The drug CALDOPA contains one active pharmaceutical ingredient (API):

1	Alphamethyldopa UNII 56LH93261Y - METHYLDOPA
	Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
	Read more about Alphamethyldopa

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-8495	Tablet	CALDOPA TABLET TAB 250 mg 10 X 10	26 RNW-PP-329830 CALDOPA TABLET METHYLDOPA METHYLDOPA (METHYLDOPA SEQUIHYDRATE 1.13G IS EQUIVALENT TO 1G ANHYDROUS METHYLDOPA) 70.625KG, CITRIC ACID ANHYDROUS 2.475KG, MICROCRYSTALLINE CELLULOSE (pH 101) 21.295KG, POLYVINYL PYRROLIDONE (K-30) 3.000KG, YELLOW IRON OXIDE 0.100KG, ISOPROPYL ALCOHOL (FOR GRANULATION) 20.498KG, SODIUM STARCH GLYCOLATE 1.505KG, MAGNESSIUM STEARATE 1.000KG Apr-95 Drugs Nigerian Products 10x10 POM 1 4/28/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02AB02	Methyldopa (racemic)	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-8495